Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1191070 · FYE Jun 30 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $3.92Day +3.16%Mkt cap $21M1Y −38.2%Off 52W high −76.4%Vol (1Y) 128.0%
Daily closing price, split-adjusted to the current basis; 1.5y shown of 389 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.3% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.71% |
| Top-10 13F concentration94.6% |
| Next report (est.)2026-08-15 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$15.6M |
| Earnings (TTM)-$17.4M |
| ROE−2.0% |
| Net margin−2.4% |
| ROIC−18.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+29.9% |
| 1Y−38.2% |
| Since incept. (ann.)−15.8% |
Total return through 2026-07-30 · series begins 2024-12-24. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)128.0% |
| Ann. volatility (3Y)115.2% |
| Sharpe (1Y)0.36 |
| Sharpe (3Y)0.53 |
| Max drawdown (1Y)−81.4% |
| Max drawdown (3Y)−81.4% |
| Beta (3Y vs SPY)1.96 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Lynx1 Capital Management LP | 875,328 | $4M | 16.24% | +0.0% |
| AdvisorShares Investments LLC | 155,367 | $632,344 | 2.88% | +15.8% |
| Shay Capital LLC | 151,010 | $614,611 | 2.80% | −10.7% |
| Balyasny Asset Management L.P. | 142,183 | $578,685 | 2.64% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 98,516 | $400,960 | 1.83% | new |
| Squadron Capital Management LLC | 76,728 | $312,283 | 1.42% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 52,007 | $211,668 | 0.96% | +200.6% |
| Ikarian Capital, LLC | 47,443 | $193,093 | 0.88% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.09 | −101.4% | — | — |
| 2025-12-31 | 2026-02-17 | −$0.77 | — | — | — |
| 2025-09-30 | 2025-11-14 | −$4.41 | — | — | — |
| 2025-03-31 | 2025-05-20 | $6.55 | — | $15.0M | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-15 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
